We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





AITbiotech Exhibits abTES Molecular Diagnostics Assays at MEDLAB 2017

By LabMedica International staff writers
Posted on 09 Feb 2017
AITbiotech Pte Ltd., a Singapore-based genomic service and molecular diagnostics (MDx) company, exhibited its comprehensive range of abTES MDx assays, including its newly launched Zika assays and the multiplex respiratory panel, at MEDLAB 2017, the world’s largest laboratory exhibition and congress in the Middle East.

AITbiotech provides a complete suite of genomic services, including capillary sequencing, next-generation sequencing services, bioinformatics services and customized molecular services, to the research, healthcare and biomedical industries in Singapore and Asia. More...
The company also manufactures and distributes its own line of real-time PCR pathogen detection assays branded as abTES in the Asian and European markets.

At MEDLAB 2017, held at the Dubai International Convention & Exhibition Centre, UAE, from February 6-9, 2017, AITbiotech showcased its abTES MDx range of assays, which uses real-time PCR (qPCR) technology to offer unsurpassed sensitivity and specificity, thus allowing for accurate detection of pathogens within hours. AITbiotech’s assays with internal control for simultaneous detection and differentiation of infectious pathogens are compatible with various platforms. Its timesaving and user-oriented protocols ensure fast turnaround time, from sample to results in 3.5 hours.

Alex Thian, CEO of AITbiotech, said, “We are excited to be part of this premier exhibition. After many years of development of our assays and focusing in the Asia Pacific market, we are finally are able to expand to more markets. We believe that Middle East will be the best market for us to expand into, primarily due to the relevance of our abTES assay offerings to the needs of the Middle East Market. We are looking for local partners to work with us collaboratively to introduce our abTES MDx assays to the Middle East market.”


New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Collection and Transport System
PurSafe Plus®
Alcohol Testing Device
Dräger Alcotest 7000
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.